Catalyst Event
Medtronic PLC (MDT) · Other
From KEDI U.S. Humanoid Robot Index (KUHMRB)
3/23/2026, 12:00:00 AM
Received U.S. FDA approval on March 23, 2026, for an expanded indication for the OmniaSecure™ defibrillation lead, making it the first approved for placement in the left bundle branch area for conduction system pacing.
Korean Translation
2026년 3월 23일, 미국 FDA로부터 OmniaSecure™ 제세동기 리드의 적응증 확대 승인을 획득함. 이는 전도 시스템 페이싱을 위해 좌측 다발 분지 영역에 삽입이 승인된 최초의 사례임.
Related Recent Events
Medtronic PLC (MDT) · Earnings Release
Q4 and Full-Year Fiscal 2026 earnings release on May 20, 2026, scheduled. Low importance is estimated as it is a routine financial reporting event.
5/20/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q1 2026 earnings release scheduled for May 5, 2026. The company guided for Q1 revenue of approximately $9.8 billion, representing ~32% year-over-year growth but a sequential decline. Analysts forecast EPS of ~$1.27. Medium market impact as a major quarterly catalyst expected.
5/5/2026, 12:00:00 AM
Meta Platforms Inc (META) · Earnings Release
Meta is scheduled to report its Q1 2026 financial results on 2026-04-29; low importance as the announcement of the reporting date typically has a price impact of less than 1%, scheduled.
4/29/2026, 12:00:00 AM
QUALCOMM Inc. (QCOM) · Earnings Release
Q2 Fiscal 2026 earnings release is scheduled.
4/29/2026, 12:00:00 AM
Tesla Inc (TSLA) · Earnings Release
Q1 2026 earnings release on 2026-04-28 with high impact expected due to focus on margins and AI scheduled.
4/28/2026, 12:00:00 AM
Manhattan Associates Inc (MANH) · Earnings Release
Manhattan Associates' Q1 2026 earnings release is scheduled.
4/28/2026, 12:00:00 AM